Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on December 31, 2025

Dec. 31, 2025

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

GlobeNewswire

Dec. 31, 2025

Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

Dec. 31, 2025

LuluTox Detox Tea Unveiled: Why Lulutox Tea Being Discussed as the Best Herbal Weight Loss Tea Blend for Women to Burn Fat in 2026

GlobeNewswire

Dec. 31, 2025

Alvotech Secures Term Loan Facility of USD 100 Million

GlobeNewswire

Dec. 31, 2025

Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD

GlobeNewswire

Dec. 31, 2025

Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

GlobeNewswire

Dec. 31, 2025

River Oaks Treatment Center Offers Expanded Mental Health Services as the New Year Brings Increased Focus on Wellness

GlobeNewswire

Dec. 31, 2025

Laguna Treatment Center Strengthens Clinical Team with New Behavioral Health Therapist

GlobeNewswire

Dec. 31, 2025

New Year, New Mission: Oxford Treatment Center Empowers Veterans to Reclaim Their Lives in 2026

GlobeNewswire

Dec. 31, 2025

Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement

GlobeNewswire

Dec. 31, 2025

Valneva et le Serum Institute of India annoncent la fin de leur accord de licence pour le vaccin contre le chikungunya

GlobeNewswire

Dec. 31, 2025

Total number of shares and voting rights in Zealand Pharma as of December 31, 2025

GlobeNewswire

Dec. 31, 2025

BioNTX Marks the Close of the First Quarter of the 21st Century with Growth, Workforce Momentum, and Innovation Leadership

GlobeNewswire

Dec. 31, 2025

Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

Dec. 31, 2025

Why Most New Year’s Resolutions Fail by January—And How to Make Them Stick in 2026

GlobeNewswire

Dec. 31, 2025

Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins

GlobeNewswire

Dec. 31, 2025

ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Dec. 31, 2025

FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis

GlobeNewswire

Dec. 31, 2025

Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders

GlobeNewswire

Dec. 31, 2025

Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders

GlobeNewswire